As of April 19, 2025, 23andMe (ME) has a market cap of $13.335 million USD. According to our data, 23andMe is ranked No.8695 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $13.34 M |
-79.19%
|
Dec 31, 2024 | $64.10 M |
-82.22%
|
Dec 29, 2023 | $0.36 B |
-57.69%
|
Dec 30, 2022 | $0.85 B |
-67.57%
|
Dec 31, 2021 | $2.63 B |
-41.73%
|
Dec 31, 2020 | $4.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Illumina
ILMN
|
$11.27 B |
-0.000 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$161.38 B |
-0.001 M
|
![]() USA
|
![]() 23andMe
ME
|
$13.34 M |
-9.345 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() LabCorp
LH
|
$18.17 B |
0.001 M
|
![]() USA
|
![]() Quest Diagnostics
DGX
|
$18.18 B |
0.001 M
|
![]() USA
|
![]() Exact Sciences
EXAS
|
$7.72 B |
-0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.55 B |
0.000 M
|
![]() USA
|
![]() Veracyte
VCYT
|
$2.43 B |
0.000 M
|
![]() USA
|
Market Cap | = | ME Stock Price | * | ME Shares Outstanding |
= | $1.15 | * | 19.72 M | |
= | $13.34 M |